Security key
89357L501
Transcode Therapeutics, Inc. - Common Stock (RNAZ)
CUSIP: 89357L501
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 14,426
- Total 13F value
- $155,012
- Share change
- -15,956
- SEC-reported price per share
- $10.75
- Number of holders
- 7
- Value change
- -$83,212
- Number of buys
- 3
- Number of sells
- 5
- Shares outstanding
- 16,846,819
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
7
Top holders
7
RNAZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Transcode Therapeutics, Inc. SEC filings
Transcode Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89357L501
Recent filing periods:
Ownership snapshot
Top reported holders of RNAZ - Transcode Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
Anna Moore
Comparable rows
3/15
Latest evidence
30 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 9.9%
12 rows are not safely comparable across share classes.
13D/G row: SABBY MANAGEMENT, LLC
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 9.9%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 3
SABBY MANAGEMENT, LLC
9.9%
Thomas Joseph Tracy
5%
Anson Funds Management LP
0.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13D/G
|
9.9%
Reported 13D/G
· 31 Dec 2024
|
$26,431
69,555 shares
|
$0 | 31 Dec 2024 |
| Thomas Joseph Tracy |
13D/G
|
5%
Reported 13D/G
· 07 Mar 2025
|
$13,300
35,000 shares
|
$0 | 07 Mar 2025 |
| Anson Funds Management LP |
13D/G
|
0.1%
Reported 13D/G
· 30 Jun 2025
|
$9,494
27,125 shares
|
-$30,224 | 30 Jun 2025 |
| Anna Moore |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$791,920
1,552,785 shares
|
— | 08 Jul 2021 |
| Zdravka Medarova |
3/4/5
Chief Technology Officer, 10%+ Owner
|
—
denominator unverified
|
—
60,000 shares
|
— | 12 Dec 2022 |
| GOLDMAN SACHS GROUP INC |
13F
13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
|
—
denominator unverified
|
$218,728
28,042 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
14,426
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2026 Across Filers
Q2 2026 holders
8
Q3 2025 holders
7
Holder diff
-1
| Investor | Q2 2026 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend